{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:11:18Z","timestamp":1777414278497,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.exphem.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T06:31:01Z","timestamp":1613543461000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice"],"prefix":"10.1016","volume":"97","author":[{"given":"Cristina","family":"Di Genua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Nerlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2021.02.006_bib0001","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","article-title":"Acute erythroid leukemia","volume":"134","author":"Zuo","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.exphem.2021.02.006_bib0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2010.194","article-title":"Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification","volume":"24","author":"Liu","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","article-title":"Erythroleukemia\u2014historical perspectives and recent advances in diagnosis and management","volume":"32","author":"Boddu","year":"2018","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2021.02.006_bib0004","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0006","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","article-title":"Genomic subtyping and therapeutic targeting of acute erythroleukemia","volume":"51","author":"Iacobucci","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2021.02.006_bib0007","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0008","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/modpathol.2010.96","article-title":"Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease","volume":"23","author":"Kasyan","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1309\/AJCPRKYAT6EZQHC7","article-title":"Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics: a guide to a number of perplexing entities","volume":"144","author":"Wang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0010","first-page":"267","article-title":"Machine learning algorithms for diagnosis of leukemia","volume":"9","author":"Maria","year":"2020","journal-title":"Int J Sci Technol Res"},{"key":"10.1016\/j.exphem.2021.02.006_bib0011","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0012","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1038\/bcj.2017.68","article-title":"Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification","volume":"7","author":"Cervera","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2021.02.006_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/leu.2016.162","article-title":"Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia","volume":"31","author":"Ping","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.02.006_bib0014","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/leu.2013.144","article-title":"Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics","volume":"27","author":"Grossmann","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.02.006_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.2019003062","article-title":"Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers","volume":"136","author":"Fagnan","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0016","first-page":"3399","article-title":"CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population","volume":"9","author":"Su","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.exphem.2021.02.006_bib0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-018-0566-8","article-title":"Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population","volume":"11","author":"Wei","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0018","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12885-017-3528-6","article-title":"An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification","volume":"17","author":"Qiu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2021.02.006_bib0019","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1038\/sj.onc.1205442","article-title":"Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus","volume":"21","author":"Finkelstein","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2021.02.006_bib0020","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.74.7.3037-3045.2000","article-title":"Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins","volume":"74","author":"Nishigaki","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/331277a0","article-title":"Spi-1 is a putative oncogene in virally induced murine erythroleukaemias","volume":"331","author":"Moreau-Gachelin","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2021.02.006_bib0022","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus","volume":"87","author":"Ben-David","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2021.02.006_bib0023","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1101\/gad.12.15.2403","article-title":"PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors","volume":"12","author":"Nerlov","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2021.02.006_bib0024","first-page":"2967","article-title":"Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells","volume":"12","author":"Schuetze","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1128\/MCB.19.1.121","article-title":"Spi-1\/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines","volume":"19","author":"Starck","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0026","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/bloodadvances.2019000761","article-title":"The ParaHox gene Cdx4 induces acute erythroid leukemia in mice","volume":"3","author":"Thoene","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2021.02.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.03.022","article-title":"C\/EBPalpha and GATA-2 mutations induce bilineage acute erythroid leukemia through transformation of a neomorphic neutrophil\u2013erythroid progenitor","volume":"37","author":"Di Genua","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2021.02.006_bib0028","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/leu.2012.174","article-title":"GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis","volume":"27","author":"Fasan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.02.006_bib0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrc1363","article-title":"C\/EBPalpha mutations in acute myeloid leukaemias","volume":"4","author":"Nerlov","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2021.02.006_bib0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ncb1960","article-title":"C\/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation","volume":"11","author":"Lopez","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0031","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ccr.2009.09.036","article-title":"Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C\/EBPalpha mutant AML","volume":"16","author":"Bereshchenko","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2021.02.006_bib0032","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2021.02.006_bib0033","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ajmg.a.33445","article-title":"Emberger syndrome\u2014primary lymphedema with myelodysplasia: report of 7 new cases","volume":"152A","author":"Mansour","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.exphem.2021.02.006_bib0034","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0035","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2021.02.006_bib0038","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2008.02.008","article-title":"Modeling of C\/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells","volume":"13","author":"Kirstetter","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2021.02.006_bib0040","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/leu.2012.37","article-title":"Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model","volume":"26","author":"Reckzeh","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2021.02.006_bib0041","doi-asserted-by":"crossref","first-page":"eaau7148","DOI":"10.1126\/sciimmunol.aau7148","article-title":"Identification of 2 distinct pathways of human myelopoiesis","volume":"4","author":"Drissen","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0042","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1111\/bjh.16586","article-title":"Gains of EPOR and ERG genes in adult erythroleukaemia","volume":"189","author":"Ad\u00e9la\u00efde","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2021.02.006_bib0043","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2014-08-594648","article-title":"Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation","volume":"125","author":"Mayle","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2021.02.006_bib0044","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2021.02.006_bib0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/ijms18040837","article-title":"Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: a retrospective multinational study","volume":"18","author":"Almeida","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2021.02.006_bib0046","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.3324\/haematol.2016.148999","article-title":"Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia","volume":"101","author":"Coombs","year":"2016","journal-title":"Haematologica"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X21000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:35:41Z","timestamp":1759566941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X21000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"alternative-id":["S0301472X21000837"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2021.02.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}